GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1‐mediated BMP‐SMAD signalling suppression. (16th August 2019)

• Record Type: Journal Article
• Authors: Fang, Zheng; Zhu, Zesen; Zhang, Haihang; Peng, Yuanliang; Liu, Jin; Lu, Hongyu; Li, Jiang; Liang, Long; Xia, Shenghua; Wang, Qiguang; Fu, Bin; Wu, Kunlu; Zhang, Lingqiang; Ginzburg, Yelena; Liu, Jing; Chen, Huiyong
• Is Part Of: British journal of haematology. Volume 188:Number 2(2020)
• Page Start: 321
• Page End: 331
• Publication Date: 2019-08-16
• Subjects: iron -- erythropoiesis -- hepcidin/HAMP -- GDF11 -- erythroid factor; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; 616.15
• DOI: 10.1111/bjh.16156
• Languages: English
• ISSNs: 0007-1048

Abstract

Summary: Hepcidin (HAMP) synthesis is suppressed by erythropoiesis to increase iron availability for red blood cell production. This effect is thought to result from factors secreted by erythroid precursors. Growth differentiation factor 11 (GDF11) expression was recently shown to increase in erythroid cells of β‐thalassaemia, and decrease with improvement in anaemia. Whether GDF11 regulates hepatic HAMP production has never been experimentally studied. Here, we explore GDF11 function during erythropoiesis‐triggered HAMP suppression. Our results confirm that exogenous erythropoietin significantly increases Gdf11 as well as Erfe (erythroferrone) expression, and Gdf11 is also increased, albeit at a lower degree than Erfe, in phlebotomized wild type and β‐thalassaemic mice. GDF11 is expressed predominantly in erythroid burst forming unit‐ and erythroid colony‐forming unit‐ cells during erythropoiesis. Exogeneous GDF11 administration results in HAMP suppression in vivo and in vitro . Furthermore, exogenous GDF11 decreases BMP‐SMAD signalling, enhances SMAD ubiquitin regulatory factor 1 (SMURF1) expression and induces ERK1/2 (MAPK3/1) signalling. ERK1/2 signalling activation is required for GDF11 or SMURF1‐mediated suppression in BMP‐SMAD signalling and HAMP expression. This research newly characterizes GDF11 in erythropoiesis‐mediated HAMP suppression, in addition to ERFE.